Clinical Trial

ConvaVAC™ Ag+ Negative Pressure Wound Therapy System in Chronic Wounds

Study acronym: ConvaVAC VLU
Recruiting
View on ClinicalTrials.gov →
Summary
Purpose of this study is to learn more about how safe and effective the ConvaVAC™ Ag+ wound therapy system is in treating certain types of long-lasting wounds, called chronic wounds. In this study, the focus is on Venous Leg Ulcers (VLUs). Chronic wounds are wounds that do not heal properly or take a long time to heal. They can cause pain, discomfort, and affect your day-to-day life. These types of wounds are also challenging for healthcare teams to treat and can take up a lot of healthcare resources. Venous Leg Ulcers (VLUs) are the most common type of chronic leg wound and affect about 1 in every 100 people. Usual treatments for VLUs include cleaning the wound, using special dressings, applying pressure (compression therapy), and sometimes using creams or dressings that contain silver to fight infection. This study is being done to see if the wound therapy system can help heal venous leg ulcers more effectively and safely.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-07-10
notable Trial sites expanded: 0 -> 7 locations 2026-07-10
Trial Details
NCT Number NCT07342049
Lead Sponsor ConvaTec Inc.
Conditions Venous Leg Ulcer (VLU)
Enrollment 87 participants
Start Date 2026-01-12
Primary Completion 2026-10-30 (estimated)
Study Completion 2026-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-09